WHO reports trachoma intervention need falls below 100 million for first time

The World Health Organization reported that people requiring trachoma interventions fell to 97.1 million by November 2025, a 94 percent reduction since 2011 and the first time below 100 million. The milestone reinforces how sustained, data-driven public health interventions deliver measurable social returns, a model relevant to ESG-aligned health investments in India.

The World Health Organization reported that the number of people requiring interventions against trachoma, the world's leading infectious cause of blindness, fell below 100 million for the first time in history. In 2002, 1.5 billion people were at risk, and as recently as 2011, 314 million required interventions. The decline to 97.1 million by November 2025 represents a 94 percent reduction, credited to the WHO-endorsed SAFE strategy combining Surgery for trachomatous trichiasis, Antibiotics, Facial cleanliness, and Environmental improvement.

Countries across Africa, Asia, and the Middle East are directly affected, with national health ministries partnering with local communities and international organisations to ensure widespread reach and sustainability. Endemic regions benefit from large-scale antibiotic distribution campaigns, targeted surgical interventions, and educational programmes promoting facial hygiene and improved sanitation. Innovative data collection tools, including Tropical Data systems, have helped track progress and allocate resources effectively, ensuring interventions reach the most vulnerable populations and strengthen health systems in affected regions.

Donors, governments, and private partners should note the value of long-term investments in preventive healthcare and data-driven implementation to deliver measurable social and economic returns. The WHO achievement provides a model for other infectious disease elimination campaigns, reinforcing compliance with global health standards and ESG principles in the health sector. Stakeholders should monitor how structured, evidence-based interventions achieve tangible impact, prevent avoidable blindness, and strengthen health systems as a benchmark for sustained multi-level public health action.

Key figure — Trachoma intervention need: 97.1 million by November 2025, a 94 percent reduction since 2011